Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma
2018-01-01 Montironi, R; Cimadamore, A; Gasparrini, S; Mazzucchelli, R; Santoni, M; Massari, F; Cheng, L; Lopez-Beltran, A; Scarpelli, M.
Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors
2020-01-01 Santoni, M.; Heng, D. Y.; Bracarda, S.; Procopio, G.; Milella, M.; Porta, C.; Matrana, M. R.; Carteni, G.; Crabb, S. J.; De Giorgi, U.; Basso, U.; Masini, C.; Calabro, F.; Vitale, M. G.; Santini, D.; Massari, F.; Galli, L.; Fornarini, G.; Ricotta, R.; Buti, S.; Zucali, P.; Caffo, O.; Morelli, F.; Carrozza, F.; Martignetti, A.; Gelibter, A.; Iacovelli, R.; Mosca, A.; Atzori, F.; Vau, N.; Incorvaia, L.; Ortega, C.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Paolucci, V.; Graham, J.; Pierce, E.; Scagliarini, S.; Sepe, P.; Verzoni, E.; Merler, S.; Rizzo, M.; Sorgentoni, G.; Conti, A.; Piva, F.; Cimadamore, A.; Montironi, R.; Battelli, N.
Re: Human Chimeric Antigen Receptor Macrophages for Cancer Immunotherapy
2021-01-01 Santoni, M.; Massari, F.; Santoni, G.; Cimadamore, A.; Montironi, R.; Battelli, N.
Digital frozen section of the prostate surface during radical prostatectomy: a novel approach to evaluate surgical margins
2020-01-01 Rocco, B.; Sighinolfi, M. C.; Cimadamore, A.; Reggiani Bonetti, L.; Bertoni, L.; Puliatti, S.; Eissa, A.; Spandri, V.; Azzoni, P.; Dinneen, E.; Shaw, G.; Nathan, S.; Micali, S.; Bianchi, G.; Maiorana, A.; Pellacani, G.; Montironi, R.
An update on investigational therapies that target STAT3 for the treatment of cancer
2021-01-01 Santoni, M.; Miccini, F.; Cimadamore, A.; Piva, F.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.; Battelli, N.
Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?
2022-01-01 Cimadamore, A.; Lonati, C.; Di Trapani, E.; De Cobelli, O.; Rink, M.; Zamboni, S.; Simeone, C.; Soria, F.; Briganti, A.; Montorsi, F.; Afferi, L.; Mattei, A.; Carando, R.; Ornaghi, P. I.; Tafuri, A.; Antonelli, A.; Karnes, R. J.; Colomer, A.; Sanchez-Salas, R.; Contieri, R.; Hurle, R.; Poyet, C.; Simone, G.; D'Andrea, D.; Shariat, S. F.; Galfano, A.; Umari, P.; Francavilla, S.; Roumiguie, M.; Terrone, C.; Hendricksen, K.; Krajewski, W.; Buisan, O.; Laukhtina, E.; Xylinas, E.; Alvarez-Maestro, M.; Roupret, M.; Montironi, R.; Moschini, M.
Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors
2020-01-01 Mollica, V.; Maggio, I.; Lopez-Beltran, A.; Montironi, R.; Cimadamore, A.; Cheng, L.; Rizzo, A.; Giunchi, F.; Schiavina, R.; Fiorentino, M.; Brunocilla, E.; Massari, F.
The Role of Artificial Intelligence in the Diagnosis and Prognosis of Renal Cell Tumors
2021-01-01 Giulietti, Matteo; Cecati, Monia; Sabanovic, Berina; Scirè, Andrea; Cimadamore, Alessia; Santoni, Matteo; Montironi, Rodolfo; Piva, Francesco
Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF?
2021-01-01 Mollica, V.; Rizzo, A.; Di Nunno, V.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M.; Cimadamore, A.; Montironi, R.; Massari, F.
Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View
2017-01-01 Montironi, R.; Gasparrini, S.; Cimadamore, A.; Mazzucchelli, R.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Moch, H.; Montorsi, F.; Scarpelli, M.
New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents?
2020-01-01 Aurilio, G.; Cimadamore, A.; Santoni, M.; Nole, F.; Scarpelli, M.; Massari, F.; Lopez-Beltran, A.; Cheng, L.; Montironi, R.
Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity
2022-01-01 Al-Obaidy, K. I.; Saleeb, R. M.; Trpkov, K.; Williamson, S. R.; Sangoi, A. R.; Nassiri, M.; Hes, O.; Montironi, R.; Cimadamore, A.; Acosta, A. M.; Alruwaii, Z. I.; Alkashash, A.; Hassan, O.; Gupta, N.; Osunkoya, A. O.; Sen, J. D.; Baldrige, L. A.; Sakr, W. A.; Idrees, M. T.; Eble, J. N.; Grignon, D. J.; Cheng, L.
Circulating tumor cells in renal cell carcinoma: Recent findings and future challenges
2019-01-01 Santoni, M.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Scarpelli, M.; Galosi, A. B.; Bracarda, S.; Montironi, R.
Immunotherapy and radiation therapy in renal cell carcinoma
2020-01-01 Mollica, V.; Santoni, M.; Di Nunno, V.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Battelli, N.; Montironi, R.; Massari, F.
Upper urinary tract urothelial carcinoma and its variants: transition from morphology to personalized molecular characterization in diagnosis, prognosis, and therapy
2018-01-01 Cimadamore, A.; Scarpelli, M.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.
Predicting future cancer burden in the United States by artificial neural networks
2020-01-01 Piva, Francesco; Tartari, Francesca; Giulietti, Matteo; Aiello, Marco Maria; Cheng, Liang; Lopez-Beltran, Antonio; Mazzucchelli, Roberta; Cimadamore, Alessia; Cerqueti, Roy; Battelli, Nicola; Montironi, Rodolfo; Santoni, Matteo
Syndrome of inappropriate antidiuresis in prostate adenocarcinoma with neuroendocrine differentiation: a case report and literature review
2019-01-01 Fiordoliva, Ilaria; Marcantognini, Giulia; Rinaldi, Silvia; Cimadamore, Alessia; Montironi, Rodolfo; Berardi, Rossana
Uropathologists During the COVID-19 Pandemic: What Can Be Learned in Terms of Social Interaction, Visibility, and Social Distance
2020-01-01 Montironi, R; Cheng, L; Cimadamore, A; Lopez-Beltran, A; Scarpelli, M
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy
2020-01-01 Cimadamore, A.; Lopez-Beltran, A.; Massari, F.; Santoni, M.; Mazzucchelli, R.; Scarpelli, M.; Galosi, A. B.; Cheng, L.; Montironi, R.
Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis
2020-01-01 Cantini, L.; Pecci, F.; Murrone, A.; Tomasetti, M.; Copparoni, C.; Fiordoliva, I.; Morgese, F.; Rinaldi, S.; Mazzanti, P.; Rubini, C.; Cimadamore, A.; Barbisan, F.; Giampieri, R.; Scarpelli, M.; Santarelli, L.; Berardi, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma | 1-gen-2018 | Montironi, R; Cimadamore, A; Gasparrini, S; Mazzucchelli, R; Santoni, M; Massari, F; Cheng, L; Lopez-Beltran, A; Scarpelli, M. | |
| Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors | 1-gen-2020 | Santoni, M.; Heng, D. Y.; Bracarda, S.; Procopio, G.; Milella, M.; Porta, C.; Matrana, M. R.; Carteni, G.; Crabb, S. J.; De Giorgi, U.; Basso, U.; Masini, C.; Calabro, F.; Vitale, M. G.; Santini, D.; Massari, F.; Galli, L.; Fornarini, G.; Ricotta, R.; Buti, S.; Zucali, P.; Caffo, O.; Morelli, F.; Carrozza, F.; Martignetti, A.; Gelibter, A.; Iacovelli, R.; Mosca, A.; Atzori, F.; Vau, N.; Incorvaia, L.; Ortega, C.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Paolucci, V.; Graham, J.; Pierce, E.; Scagliarini, S.; Sepe, P.; Verzoni, E.; Merler, S.; Rizzo, M.; Sorgentoni, G.; Conti, A.; Piva, F.; Cimadamore, A.; Montironi, R.; Battelli, N. | |
| Re: Human Chimeric Antigen Receptor Macrophages for Cancer Immunotherapy | 1-gen-2021 | Santoni, M.; Massari, F.; Santoni, G.; Cimadamore, A.; Montironi, R.; Battelli, N. | |
| Digital frozen section of the prostate surface during radical prostatectomy: a novel approach to evaluate surgical margins | 1-gen-2020 | Rocco, B.; Sighinolfi, M. C.; Cimadamore, A.; Reggiani Bonetti, L.; Bertoni, L.; Puliatti, S.; Eissa, A.; Spandri, V.; Azzoni, P.; Dinneen, E.; Shaw, G.; Nathan, S.; Micali, S.; Bianchi, G.; Maiorana, A.; Pellacani, G.; Montironi, R. | |
| An update on investigational therapies that target STAT3 for the treatment of cancer | 1-gen-2021 | Santoni, M.; Miccini, F.; Cimadamore, A.; Piva, F.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Montironi, R.; Battelli, N. | |
| Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy? | 1-gen-2022 | Cimadamore, A.; Lonati, C.; Di Trapani, E.; De Cobelli, O.; Rink, M.; Zamboni, S.; Simeone, C.; Soria, F.; Briganti, A.; Montorsi, F.; Afferi, L.; Mattei, A.; Carando, R.; Ornaghi, P. I.; Tafuri, A.; Antonelli, A.; Karnes, R. J.; Colomer, A.; Sanchez-Salas, R.; Contieri, R.; Hurle, R.; Poyet, C.; Simone, G.; D'Andrea, D.; Shariat, S. F.; Galfano, A.; Umari, P.; Francavilla, S.; Roumiguie, M.; Terrone, C.; Hendricksen, K.; Krajewski, W.; Buisan, O.; Laukhtina, E.; Xylinas, E.; Alvarez-Maestro, M.; Roupret, M.; Montironi, R.; Moschini, M. | |
| Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors | 1-gen-2020 | Mollica, V.; Maggio, I.; Lopez-Beltran, A.; Montironi, R.; Cimadamore, A.; Cheng, L.; Rizzo, A.; Giunchi, F.; Schiavina, R.; Fiorentino, M.; Brunocilla, E.; Massari, F. | |
| The Role of Artificial Intelligence in the Diagnosis and Prognosis of Renal Cell Tumors | 1-gen-2021 | Giulietti, Matteo; Cecati, Monia; Sabanovic, Berina; Scirè, Andrea; Cimadamore, Alessia; Santoni, Matteo; Montironi, Rodolfo; Piva, Francesco | |
| Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF? | 1-gen-2021 | Mollica, V.; Rizzo, A.; Di Nunno, V.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Scarpelli, M.; Cimadamore, A.; Montironi, R.; Massari, F. | |
| Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View | 1-gen-2017 | Montironi, R.; Gasparrini, S.; Cimadamore, A.; Mazzucchelli, R.; Massari, F.; Cheng, L.; Lopez-Beltran, A.; Moch, H.; Montorsi, F.; Scarpelli, M. | |
| New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents? | 1-gen-2020 | Aurilio, G.; Cimadamore, A.; Santoni, M.; Nole, F.; Scarpelli, M.; Massari, F.; Lopez-Beltran, A.; Cheng, L.; Montironi, R. | |
| Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity | 1-gen-2022 | Al-Obaidy, K. I.; Saleeb, R. M.; Trpkov, K.; Williamson, S. R.; Sangoi, A. R.; Nassiri, M.; Hes, O.; Montironi, R.; Cimadamore, A.; Acosta, A. M.; Alruwaii, Z. I.; Alkashash, A.; Hassan, O.; Gupta, N.; Osunkoya, A. O.; Sen, J. D.; Baldrige, L. A.; Sakr, W. A.; Idrees, M. T.; Eble, J. N.; Grignon, D. J.; Cheng, L. | |
| Circulating tumor cells in renal cell carcinoma: Recent findings and future challenges | 1-gen-2019 | Santoni, M.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Battelli, N.; Massari, F.; Scarpelli, M.; Galosi, A. B.; Bracarda, S.; Montironi, R. | |
| Immunotherapy and radiation therapy in renal cell carcinoma | 1-gen-2020 | Mollica, V.; Santoni, M.; Di Nunno, V.; Cimadamore, A.; Cheng, L.; Lopez-Beltran, A.; Battelli, N.; Montironi, R.; Massari, F. | |
| Upper urinary tract urothelial carcinoma and its variants: transition from morphology to personalized molecular characterization in diagnosis, prognosis, and therapy | 1-gen-2018 | Cimadamore, A.; Scarpelli, M.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Montironi, R. | |
| Predicting future cancer burden in the United States by artificial neural networks | 1-gen-2020 | Piva, Francesco; Tartari, Francesca; Giulietti, Matteo; Aiello, Marco Maria; Cheng, Liang; Lopez-Beltran, Antonio; Mazzucchelli, Roberta; Cimadamore, Alessia; Cerqueti, Roy; Battelli, Nicola; Montironi, Rodolfo; Santoni, Matteo | |
| Syndrome of inappropriate antidiuresis in prostate adenocarcinoma with neuroendocrine differentiation: a case report and literature review | 1-gen-2019 | Fiordoliva, Ilaria; Marcantognini, Giulia; Rinaldi, Silvia; Cimadamore, Alessia; Montironi, Rodolfo; Berardi, Rossana | |
| Uropathologists During the COVID-19 Pandemic: What Can Be Learned in Terms of Social Interaction, Visibility, and Social Distance | 1-gen-2020 | Montironi, R; Cheng, L; Cimadamore, A; Lopez-Beltran, A; Scarpelli, M | |
| Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy | 1-gen-2020 | Cimadamore, A.; Lopez-Beltran, A.; Massari, F.; Santoni, M.; Mazzucchelli, R.; Scarpelli, M.; Galosi, A. B.; Cheng, L.; Montironi, R. | |
| Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis | 1-gen-2020 | Cantini, L.; Pecci, F.; Murrone, A.; Tomasetti, M.; Copparoni, C.; Fiordoliva, I.; Morgese, F.; Rinaldi, S.; Mazzanti, P.; Rubini, C.; Cimadamore, A.; Barbisan, F.; Giampieri, R.; Scarpelli, M.; Santarelli, L.; Berardi, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista47360
- 2 Contributo in Volume1
- 3 Libro1
Data di pubblicazione
- In corso di stampa37
- 2020 - 202713529
- 2010 - 201915290
- 2000 - 200910528
- 1990 - 19995844
- 1980 - 19891783
- 1970 - 1979315
- 1960 - 196935
Editore
- Elsevier BV:PO Box 211, 1000 AE A...288
- American Institute of Physics:2 H...269
- Germany: Springer Verlag Germany101
- Elsevier Science Limited:Oxford F...71
- Elsevier Science Incorporated / N...60
- Springer Verlag Germany:Tiergarte...57
- Taylor & Francis Limited:Rankine ...56
- Edizioni Minerva Medica:Corso Bra...52
- S Karger AG:Allschwilerstrasse 10...48
- Annals Publishing Company:4507 La...47
Rivista
- PHYSICAL REVIEW LETTERS520
- PHYSICS LETTERS. SECTION B491
- THE EUROPEAN PHYSICAL JOURNAL. C,...451
- JOURNAL OF HIGH ENERGY PHYSICS351
- PHYSICAL REVIEW D, PARTICLES, FIE...305
- NUCLEAR INSTRUMENTS & METHODS IN ...202
- PHYSICAL REVIEW D157
- THE ASTROPHYSICAL JOURNAL156
- PLOS ONE149
- SCIENTIFIC REPORTS133
Serie
- REGIONAL DOSSIERS SERIES1
Keyword
- Humans1080
- Female609
- Male544
- Middle Aged356
- Italy330
- Adult316
- COVID-19313
- Medicine (all)282
- Aged281
- Biochemistry192
Lingua
- eng30123
- ita9631
- fre359
- spa205
- ger192
- rus48
- fur28
- und27
- lat25
- pol25
Accesso al fulltext
- no fulltext32298
- open8479
- reserved6158
- partially open395
- restricted18
- embargoed10
- mixed3